21.2.2022
XO Life makes real-world patient data accessible
The start-up XO Life is developing a platform to share patient data with pharmaceutical companies anonymously.
Startp XO Life uses real world data to optimize the healthcare sector
The systematic use and structuring of patient data derived from reviews of doctor visits or medication intake is becoming an important health aspect. XO Life has recognized that such, often unstructured data can represent a new business area if processed correctly. This so-called real world data is already being found by buyers in the pharmaceutical industry, mail-order drug retailers and even in legislative bodies, all of which are looking for valid data sources to optimize their products and policies.
Would you like to find out more or are you interested in XO Life?
Get in touch now, get a demo or answer individual questions in a personal conversation.
XO Life News
Discover even more news
Glenmark launcht eigenen Bereich für Malaria-Prophylaxe und -Therapie auf der ImpactMonitor™-Plattform von XO Life
Glenmark und XO Life bieten Patienten digitalen Support auf der ImpactMonitor™ Plattform an.
Dr. Gustav Klein and XO Life: Digital therapy support for users of Gastritol® Liquid for gastrointestinal complaints
Gastritol® Liquid now offers digital therapy support via XO Life's ImpactMonitor™ platform.
XO Life receives 7 Million Euros for the international expansion of its health platform as an alternative to Google, Facebook and Co.
XO Life secures €7 million for global expansion of its ImpactMonitor™ platform, a meta-platform for digital patient support.